跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOFILEX CAPSULE 250MG - NPRA Drug Approval Details
Approvals
/
NPRA
/
SOFILEX CAPSULE 250MG
Approved
STANDARD
SOFILEX CAPSULE 250MG
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
a0ac37193aebeb94
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Type
Standard
Approval Details
Approval Id
a0ac37193aebeb94
Drug Approval Npra Name
SOFILEX CAPSULE 250MG
Product Name
SOFILEX CAPSULE 250MG
Registration Number
MAL19970955AZ
Holder Company Name
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Holder Address
1-5, CHENG INDUSTRIAL ESTATE 75250 MALAYSIA
Holder Phone
06-3351515
Manufacturer Company Name
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Manufacturer Address
1-5 CHENG INDUSTRIAL ESTATE 75250 MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL19970955AZ
Version
1751614208
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
a0ac37193aebeb94
Type
Standard
Source
Official Source
Back to NPRA Approvals